Drug Market To Grow At A 8.14% CAGR Over 10 Years

The Chilean pharmaceutical market is the second smallest in BMI's coverage of the Latin American region, trailed only by Peru. Nevertheless, Chile offers considerable longer-term benefits to foreign companies, as the absolute size of its drug market is expected to grow as public health coverage expands. Although the market is relatively well-developed compared with others in the region, many poorer people are yet to receive comprehensive healthcare coverage. In the meantime, the country's economic development is forecast to experience modest growth, with real GDP growth and fiscal expenditure expected to increase and provide a solid foundation for the further growth

To read the full article, please choose one of the following options: